Fibroblast growth factor 23 (FGF-23) is an early predictor of mortality in patients with cardiac arrest

Aune, 2011, Improvement in the hospital organisation of CPR training and outcome after cardiac arrest in Sweden during a 10-year period, Resuscitation, 82, 431, 10.1016/j.resuscitation.2010.11.021 Wissenberg, 2015, Survival after out-of-hospital cardiac arrest in relation to age and early identification of patients with minimal chance of long-term survival, Circulation, 131, 1536, 10.1161/CIRCULATIONAHA.114.013122 Young, 2009, Clinical practice. Neurologic prognosis after cardiac arrest, N Engl J Med, 361, 605, 10.1056/NEJMcp0903466 Fogel, 1997, Serum neuron-specific enolase as early predictor of outcome after cardiac arrest, Crit Care Med, 25, 1133, 10.1097/00003246-199707000-00012 Schefold, 2009, The Glasgow Coma Score is a predictor of good outcome in cardiac arrest patients treated with therapeutic hypothermia, Resuscitation, 80, 658, 10.1016/j.resuscitation.2009.03.006 Shinozaki, 2011, Blood ammonia and lactate levels on hospital arrival as a predictive biomarker in patients with out-of-hospital cardiac arrest, Resuscitation, 82, 404, 10.1016/j.resuscitation.2010.10.026 Mulder, 2014, Awakening and withdrawal of life-sustaining treatment in cardiac arrest survivors treated with therapeutic hypothermia, Crit Care Med, 42, 2493, 10.1097/CCM.0000000000000540 Friberg, 2015, Survey on current practices for neurological prognostication after cardiac arrest, Resuscitation, 90, 158, 10.1016/j.resuscitation.2015.01.018 Gruson, 2012, C-terminal FGF23 is a strong predictor of survival in systolic heart failure, Peptides, 37, 258, 10.1016/j.peptides.2012.08.003 Plischke, 2012, Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure, Eur J Clin Invest, 42, 649, 10.1111/j.1365-2362.2011.02631.x Panwar, 2015, Fibroblast growth factor 23 and risk of incident stroke in community-living adults, Stroke, 46, 322, 10.1161/STROKEAHA.114.007489 Mathew, 2014, Fibroblast growth factor-23 and incident atrial fibrillation: the multi-ethnic study of atherosclerosis (MESA) and the cardiovascular health study (CHS), Circulation, 130, 298, 10.1161/CIRCULATIONAHA.113.005499 Yamashita, 2000, Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain, Biochem Biophys Res Commun, 277, 494, 10.1006/bbrc.2000.3696 Gutierrez, 2005, Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease, J Am Soc Nephrol, 16, 2205, 10.1681/ASN.2005010052 Gutierrez, 2008, Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis, N Engl J Med, 359, 584, 10.1056/NEJMoa0706130 Isakova, 2011, Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease, JAMA: J Am Med Assoc, 305, 2432, 10.1001/jama.2011.826 Ix, 2012, Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study), J Am Coll Cardiol, 60, 200, 10.1016/j.jacc.2012.03.040 Faul, 2011, FGF23 induces left ventricular hypertrophy, J Clin Invest, 121, 4393, 10.1172/JCI46122 Itoh, 2013, Pathophysiological roles of FGF signaling in the heart, Front Physiol, 4, 247, 10.3389/fphys.2013.00247 Touchberry, 2013, FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy, Am J Physiol Endocrinol Metab, 304, E863, 10.1152/ajpendo.00596.2012 Poss, 2013, FGF-23 is associated with increased disease severity and early mortality in cardiogenic shock, Eur Heart J Acute Cardiovasc Care, 2, 211, 10.1177/2048872613494025 Fuernau, 2014, Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the intra-aortic balloon pump in cardiogenic shock II (IABP-SHOCK II) trial, Crit Care, 18, 713, 10.1186/s13054-014-0713-8 DeLong, 1988, Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach, Biometrics, 44, 837, 10.2307/2531595 Sandroni, 2014, Prognostication in comatose survivors of cardiac arrest: an advisory statement from the European Resuscitation Council and the European Society of Intensive Care Medicine, Intensive Care Med, 40, 1816, 10.1007/s00134-014-3470-x Schoerkhuber, 1999, Time course of serum neuron-specific enolase. A predictor of neurological outcome in patients resuscitated from cardiac arrest, Stroke, 30, 1598, 10.1161/01.STR.30.8.1598 Dankiewicz, 2013, Heparin-binding protein: an early indicator of critical illness and predictor of outcome in cardiac arrest, Resuscitation, 84, 935, 10.1016/j.resuscitation.2013.01.006 Perkins, 2014, Circulation, 132, 1286, 10.1161/CIR.0000000000000144 Aschauer, 2014, A prediction tool for initial out-of-hospital cardiac arrest survivors, Resuscitation, 85, 1225, 10.1016/j.resuscitation.2014.06.007 de Borst, 2011, Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease, J Am Soc Nephrol, 22, 1603, 10.1681/ASN.2010121251 Kawai, 2014, Sympathetic activation induces skeletal Fgf23 expression in a circadian rhythm-dependent manner, J Biol Chem, 289, 1457, 10.1074/jbc.M113.500850 Vincent, 2013, Circulatory shock, N Engl J Med, 369, 1726, 10.1056/NEJMra1208943 Yilmaz, 2014, Ramipril lowers plasma FGF-23 in patients with diabetic nephropathy, Am J Nephrol, 40, 208, 10.1159/000366169 Grabner, 2015, Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy, Cell Metab, 10.1016/j.cmet.2015.09.002 Moe, 2015, Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial, Circulation, 132, 27, 10.1161/CIRCULATIONAHA.114.013876 Broessner, 2015, Outcome prediction and temperature dependency of MR-proANP and Copeptin in comatose resuscitated patients, Resuscitation, 89, 75, 10.1016/j.resuscitation.2015.01.013 Dell’anna, 2014, C-reactive protein levels after cardiac arrest in patients treated with therapeutic hypothermia, Resuscitation, 85, 932, 10.1016/j.resuscitation.2014.04.003 Gilje, 2014, The brain-enriched microRNA miR-124 in plasma predicts neurological outcome after cardiac arrest, Crit Care, 18, R40, 10.1186/cc13753 Calderon, 2014, Post Cardiac Arrest S: combining NSE and S100B with clinical examination findings to predict survival after resuscitation from cardiac arrest, Resuscitation, 85, 1025, 10.1016/j.resuscitation.2014.04.020 Donnino, 2014, Initial lactate and lactate change in post-cardiac arrest: a multicenter validation study, Crit Care Med, 42, 1804, 10.1097/CCM.0000000000000332 Leary, 2010, Neurologic prognostication and bispectral index monitoring after resuscitation from cardiac arrest, Resuscitation, 81, 1133, 10.1016/j.resuscitation.2010.04.021 Seder, 2010, The bispectral index and suppression ratio are very early predictors of neurological outcome during therapeutic hypothermia after cardiac arrest, Intensive Care Med, 36, 281, 10.1007/s00134-009-1691-1